Trials / Completed
CompletedNCT01602419
Surveillance of Safety and Efficacy of Wilate in Patients With Von Willebrand Disease
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 120 (actual)
- Sponsor
- Octapharma · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This is an observational study, hence there is no study hypothesis
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Patients using Wilate as standard of care | Patients with von Willebrand Disease using Wilate for a period of 2 years. |
Timeline
- Start date
- 2012-10-01
- Primary completion
- 2018-04-01
- Completion
- 2018-04-01
- First posted
- 2012-05-21
- Last updated
- 2021-01-19
- Results posted
- 2019-12-10
Locations
24 sites across 10 countries: United States, Argentina, Canada, Czechia, Germany, Portugal, Spain, Sweden, United Kingdom, Uruguay
Source: ClinicalTrials.gov record NCT01602419. Inclusion in this directory is not an endorsement.